Karthik G Pujar
Université Laval, Laval University, JSS Academy of Higher Education and Research, JSS Academy of Higher Education & Research
0009-0009-6897-5326
About
I am a PhD researcher in Pharmaceutical Sciences at Université Laval and the CHU de Québec–Université Laval Research Center under the supervision of Dr. Humphrey Fonge within the Oncology Research Axis.
My research interests include medicinal chemistry, drug discovery, cancer research, radiotheranostics, nuclear medicine, and translational oncology. My background combines computational drug design, molecular docking, QSAR, ADMET studies, molecular dynamics simulations, and organic synthesis.
Previously, my work focused on PDE4B-targeted heterocyclic compounds for Alzheimer’s disease, along with anti-cancer and anti-tubercular drug discovery projects. I am passionate about developing innovative therapeutic and diagnostic approaches through interdisciplinary pharmaceutical research.
Employment
-
Université Laval PhD student2025 - Present
Education
-
Laval University Doctrate in Pharmaceutical sciences2026 - Present
-
JSS Academy of Higher Education and Research M. Pharm2023 - 2025
-
JSS Academy of Higher Education & Research B. Pharm2019 - 2023
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- Modulation of PDE4 activity to counteract neurobehavioral deficits in rotenone-induced parkinsonism Save
- Synthesis of ferulic acid amide derivatives from corn leaf-isolated ferulic acid: In-vitro evaluation and computational exploration as dual anti-inflammatory and antioxidant agents Save
- Developing pyrazole–oxadiazole conjugates as potent anti-tubercular agents: an in silico and in vitro approach Save
- Gastroprotective and Antioxidant Properties of Solanum vilosum Leaf Extract Against Ethanol-Induced Gastric Ulcer: GC–MS and In Silico Insights Save
- Pharmacophore-driven design and biological evaluation of heterocyclic PDE4B inhibitors for Alzheimer's disease Save
- Novel in silico Evidence of Bisphenol A as a Neuroinflammatory Modulator through the cGAS-STING-NLRP3 Pathway Save
- Computational and experimental investigation of thiazolidinedione derivatives as PPAR-γ agonists for antidiabetic activity Save
- Design, synthesis, and antidiabetic evaluation of thiazolidinedione derivatives as potent PPAR-γ Agonists: Insights from molecular docking, MD simulations and invitro studies Save
- Novel hybrids of 1,2,3-triazole-benzoxazole: design, synthesis, and assessment of DprE1 enzyme inhibitors using fluorometric assay and computational analysis Save
- Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment Save